表紙
市場調查報告書
商品編碼
1028211

生物性保存技術市場:現狀分析與預測(2021年∼2027年)

Biopreservation Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

生物性保存技術市場,受到基因學和分子生物學進步的恩惠。已開發國家和開發中國家的生物性保存技術企業,在醫院和研究所內提供生物檢體的保存服務,在預測期間內預計生物性保存技術的引進加速。還有研究目的中導入各種生物檢體生物性保存技術,全球生物銀行的普及,也成為推動生物性保存技術市場的要素。

本報告提供全球生物性保存技術市場調查,市場概要,各類型、生物檢體、用途、終端用戶、地區的市場洞察,收益的變化與預測,市場成長要素及課題,新型冠狀病毒感染疾病(COVID-19)的影響分析,價值鏈分析,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 簡介

  • 市場定義
  • 調查目的
  • 限制
  • 相關利益者
  • 使用貨幣
  • 調查範圍

第2章 調查手法、前提條件

第3章 市場概要

第4章 摘要整理

第5章 生物性保存技術市場前幾名Start-Ups企業

第6章 新型冠狀病毒感染疾病(COVID-19)的影響

第7章 全球生物性保存技術市場收益

第8章 生物性保存技術市場洞察:各類型

  • 生物性保存技術媒體
  • 生物檢體設備
  • 冷凍庫
  • 極低溫存儲系統
  • 解凍設備
  • 冰箱

第9章 生物性保存技術市場洞察:各生物檢體

  • 人生物檢體
  • 內臟器官
  • 幹細胞
  • 其他

第10章 生物性保存技術市場洞察:各用途

  • 治療
  • 研究
  • 臨床試驗
  • 其他

第11章 生物性保存技術市場洞察:各終端用戶

  • 生物銀行
  • 遺傳基因銀行
  • 醫院
  • 其他

第12章 生物性保存技術市場洞察:各地區

  • 北美的生物性保存技術市場
    • 美國
    • 加拿大
    • 其他
  • 歐洲的生物性保存技術市場
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區的生物性保存技術市場
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他
  • 其他地區的生物性保存技術市場

第13章 市場動態

  • 市場成長要素
  • 市場課題
  • 影響分析

第14章 市場機會

第15章 與市場趨勢洞察

第16章 相關法規

第17章 需求與供給側面分析

  • 需求面分析
  • 供給側面分析
    • 主要產品的銷售
    • 商務夥伴關係
    • 合併、收購

第18章 價值鏈分析

第19章 競爭模式

  • 波特的五力分析
  • 企業的市場佔有率

第20章 企業概要

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • ThermoGenesis Holdings, Inc.
  • Bio-Techne Corporation
  • BioLife Solutions, Inc.
  • Exact Sciences Corporation
  • Princeton CryoTech, Inc.
  • Stemcell Technologies, Inc.
  • OPS Diagnostics
  • AMS Biotechnology

第21章 免責聲明

目錄
Product Code: UMHE21338

Biopreservation is a science which comprises testing the DNA and gene samples of entities so that they can be delivered with specially required nutrients, diet and healthcare services. The biopreservation market progression is likely to benefit from increasing advances in genomics and molecular biology. The prominent biopreservation firms in developed and developing nations provide in-house sample storage in hospitals and labs, is expected to accelerate the adoption of biopreservation during the forecast period. For instance, in July 2020, BioLife Solutions Inc. announced that its evo Cold Chain Management Platform supports over 100 early-stage cell & gene therapy clinical trials. Apart from this, the growing prevalence of biobanking across the world is anticipated to provide a thrust to the market, as biopreservation is used for conserving various bodily fluids and tissues for research purposes.

The Human blood, tissues, cells and organs own potential to treat damaged tissues and organs with long term benefits. The knowledge of human cells and tissues being utilized for further research and development of novel treatment therapies led to the arrival of biobanking. The growing number of biobanks across the globe is anticipated to impel the growth of biopreservation market over the forecast period. For instance, in March 2020, Columbia University Vagelos College of Physicians and Surgeons, U.S., in partnership with New York-Presbyterian Hospital, established a COVID-19 Biobank as a centralized resource to collect, store, and disseminate biological specimens and clinical data for researchers at Columbia University and elsewhere

Some of the factors which can hamper the growth of this market include high cost of biopreservation equipment's, high-cost recovery model of biobanking, lack of awareness in people about biopreservation, and constant concerns of people regarding tissue and cell injury during freezing and thawing will hinder the growth of biopreservation market in the forecast period

Since the World Health Organization (WHO) announced that Covid-19 had become a global pandemic, and it has affected almost all the sectors of the market, so it affected the biopreservation market as well. But due the emergence of COVID-19 an unexpected boost and demand for biopreservation was seen in the healthcare sector. For instance, as the biobanking operations in Canada became an essential research operation, the COVID-19-related studies were authorized and initiated. This made biobanking an essential service, which allowed for expediting COVID-19 research and sustaining essential research operations. At the peak of COVID-19 operations, the UHN Biospecimen Services has supported more than 20 essential clinical trials. Also, the major challenges faced by the biopreservation industry during Covid-19 include data management and secure exchange, due to remote operations of staff. Moreover, to tackle many different needs and responses to COVID-19, the research infrastructures, biobanks, and biopreservation firms have presented themselves on the front line.

Based on types, the market is bifurcated into biopreservation media, biospecimen equipment, freezers, cryogenic storage systems, thawing equipment, refrigerators. The biospecimen equipment segment grabbed the major market in 2020 due to the increased investments from private and public organizations for research and development of cell and gene therapies and increasing acceptance of refrigerators, and biological freezers for the preservation of biological specimens

Based on biospecimen, the market is bifurcated into human tissue samples, organs, stem cells, and others. The stem cells segment ruled the major market and accounted for the maximum share in 2020 due to the augmenting awareness of people about conserving cord blood stem cells of newborns to treat chronic diseases like cancer and others

Based on application, the market is bifurcated into therapeutic applications, research applications, clinical trials, and others. The therapeutic applications segment grabbed the major market in 2020 and accounted for the maximum revenue during the forecast period. The highest growth of this segment is accredited due to the advancements in the fields of regenerative medicine, personalized medicine and biobanking. Also, the high growth of this segment is shown due to the emergence in new treatment techniques, and high prevalence of chronic diseases across the world

Based on end-user, the market is bifurcated into biobanks, gene banks, hospitals, and others. The biobanks segment ruled the major market and accounted for the maximum share in 2020 due to the increasing demand of conserving biospecimens, tissues, organs and stem cells for various research purposes.

For a better understanding of the market adoption of Biopreservation, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for Biopreservation and generated maximum revenue in 2020 owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled professionals and physicians. Moreover, the increasing incidences of cancer and other chronic diseases are also propelling the biopreservation market in this region. For instance, according to the World Health Organization (WHO), there were approximately 300,000 cases of cancer diagnosed each year among children aged 0-19 years and almost 9.6 million people worldwide are estimated to have died from cancer in 2018

Some of the major players operating in the market include: Thermo Fisher Scientific Inc., Merck KGaA, ThermoGenesis Holdings, Inc., Bio-Techne Corporation, BioLife Solutions, Inc., Exact Sciences Corporation, Princeton CryoTech, Inc., Stemcell Technologies, Inc., OPS Diagnostics, AMS Biotechnology, etc. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions

The Biopreservation Market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021F to 2027F. The Biopreservation Market is expected to witness a boost on account of increasing demand of people towards regenerative medicine for treating and controlling various chronic diseases across the globe. Also, the growing advancements in biobanking will boost the growth of biopreservation market

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Global Biopreservation Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Biopreservation Market
    • 2.1.1 Main Objective of the Global Biopreservation Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER BIOPRESERVATION INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL BIOPRESERVATION MARKET REVENUE

8 MARKET INSIGHTS BY TYPE

  • 8.1 Biopreservation Media
  • 8.2 Biospecimen Equipment
  • 8.3 Freezers
  • 8.4 Cryogenic Storage Systems
  • 8.5 Thawing Equipment
  • 8.6 Refrigerators

9 MARKET INSIGHTS BY BIOSPECIMEN

  • 9.1 Human Tissue Samples
  • 9.2 Organs
  • 9.3 Stem Cells
  • 9.4 Others

10 MARKET INSIGHTS BY APPLICATION

  • 10.1 Therapeutic Applications
  • 10.2 Research Applications
  • 10.3 Clinical Trials
  • 10.4 Others

11 MARKET INSIGHTS BY END-USER

  • 11.1 Biobanks
  • 11.2 Gene Banks
  • 11.3 Hospitals
  • 11.4 Others

12 MARKET INSIGHTS BY REGION

  • 12.1 NORTH AMERICA BIOPRESERVATION MARKET
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Rest of North America
  • 12.2 EUROPE BIOPRESERVATION MARKET
    • 12.2.1 Germany
    • 12.2.2 France
    • 12.2.3 United Kingdom
    • 12.2.4 Spain
    • 12.2.5 Italy
    • 12.2.6 Rest of Europe
  • 12.3 ASIA PACIFIC BIOPRESERVATION MARKET
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 Australia
    • 12.3.6 Rest of Asia Pacific
  • 12.4 REST OF THE WORLD BIOPRESERVATION MARKET

13 BIOPRESERVATION MARKET DYNAMICS

  • 13.1 Market Drivers
  • 13.2 Market Challenges
  • 13.3 Impact Analysis

14 BIOPRESERVATION MARKET OPPORTUNITIES

15 BIOPRESERVATION MARKET TRENDS & INSIGHTS

16 LEGAL & REGULATORY FRAMEWORK

17 DEMAND AND SUPPLY SIDE ANALYSIS

  • 17.1 Demand Side Analysis
  • 17.2 Supply Side Analysis
    • 17.2.1 Top Product Launches
    • 17.2.2 Top Business Partnerships
    • 17.2.3 Top Merger & Acquisitions

18 VALUE CHAIN ANALYSIS

19 COMPETITIVE SCENARIO

  • 19.1 Porter's Five forces analysis
    • 19.1.1 Bargaining power of Supplier
    • 19.1.2 Bargaining power of Buyer
    • 19.1.3 Industry Rivalry
    • 19.1.4 Availability of Substitute
    • 19.1.5 Threat of new Entrants
  • 19.2 Market Share, by Company

20 COMPANY PROFILED

  • 20.1 Thermo Fisher Scientific Inc.
    • 20.1.1 Key Facts
    • 20.1.2 Business Description
    • 20.1.3 Key Product/Services Offerings
    • 20.1.4 Growth Strategy
    • 20.1.5 SWOT Analysis
    • 20.1.6 Key Financials
      • 20.1.6.1 Revenue Split
      • 20.1.6.2 Financial Overview of Thermo Fisher Scientific Inc.
    • 20.1.7 Recent Developments
      • 20.1.7.1 Product Launch
      • 20.1.7.2 Partnerships
      • 20.1.7.3 Business Expansion and Investments
      • 20.1.7.4 Merger and Acquisition
  • 20.2 Merck KGaA
  • 20.3 ThermoGenesis Holdings, Inc.
  • 20.4 Bio-Techne Corporation
  • 20.5 BioLife Solutions, Inc. 
  • 20.6 Exact Sciences Corporation
  • 20.7 Princeton CryoTech, Inc.
  • 20.8 Stemcell Technologies, Inc.
  • 20.9 OPS Diagnostics
  • 20.10 AMS Biotechnology

21 DISCLAIMER